IM
IMRSQ.US IMRIS Inc.
- Market cap
- USD 625.00
- P/E
- -
- P/B
- -
- ROE
- -257.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2014.
Is IMRSQ.US undervalued?
Graham numberThe Graham number of IMRIS Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
IMRIS Inc. fundamental analysis
No fundamental analysis for IMRIS Inc. yet.
IMRIS Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About IMRIS Inc.
IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications b…
Full company profileIMRIS Inc. financial statements
IMRIS Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 3.69M | 17.5M | 18.9M | 42.2M | 72.0M | 51.8M | 52.4M | 46.0M | 28.9M |
| Gross Profit | 1.40M | 2.27M | 4.17M | 18.7M | 31.1M | 17.7M | 17.8M | 15.7M | 9.93M |
| Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -20.6M | -26.1M | -34.1M | -23.1M |
| Net Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -20.9M | -27.8M | -42.0M | -30.4M |
| Balance Sheet | |||||||||
| Total Assets | 12.5M | 48.8M | 32.7M | 62.3M | 115M | 94.3M | 82.0M | 85.6M | 65.5M |
| Total Liabilities | 6.67M | 11.4M | 15.5M | 32.1M | 21.9M | 19.7M | 31.4M | 50.5M | 53.7M |
| Shareholders' Equity | 5.86M | 37.4M | 17.2M | 30.3M | 93.4M | 74.6M | 50.6M | 35.0M | 11.8M |
| Cash & Short-term Investments | 2.50M | 30.9M | 15.3M | 25.0M | 60.6M | 40.4M | 19.1M | 6.38M | 5.00M |
| Cash Flow | |||||||||
| Operating Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -17.9M | -15.6M | -40.6M | -10.9M |
| Capital Expenditure | 2.69M | 746K | 4.55M | 3.44M | 1.12M | 2.05M | 4.58M | 9.18M | 2.51M |
| Ratios | |||||||||
| ROE | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -28.1% | -54.9% | -119.9% | -257.7% |
| ROA | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -22.2% | -33.9% | -49.1% | -46.4% |
| Net Profit Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -40.4% | -53.0% | -91.2% | -105.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
IMRIS Inc. dividends
IMRIS Inc. has not paid dividends in the last 9 fiscal years.
Who owns IMRIS Inc.
Ownership data of IMRIS Inc. is not available yet.
IMRIS Inc. company profile
- Company name
- IMRIS Inc.
- Ticker
- IMRSQ.US
- ISIN
- CA45322N1050
- Exchange
- USA Stocks
- Listed since
- Nov 2, 2007
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 121
- Fiscal year end
- December
- Address
- 5101 Shady Oak Road, Minnetonka, MN, United States, 55343
- Phone
- 763-203-6300
- Website
- imris.com
About IMRIS Inc.
IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Minnetonka, Minnesota.
IMRIS Inc. management
8- Dr. Alma Gregory Sorensen M.D.Executive Chairman · born 1962
- Mr. Shalabh ChandraCEO & Director · born 1965
- Ms. Joanne BranandVice President Finance & IT
- Mr. Jeff BengtsonVice President of Operations, QARA and Customer Service
- Mr. Zachary OrlowskiVice President of Marketing
- Dr. Shahin PourrahimiPresident of SSI
- Mr. Alex VargasExecutive Board Member
- Mr. Matthias BerginExecutive Board Member